Metabolic & Cardiometabolic
bariatric surgery decreases cancer incidence
In plain terms: Does bariatric surgery reduce cancer incidence?
Leans support Metabolic & Cardiometabolic 🔬 Includes disconfirming
Part of: 🩺 bariatric / metabolic surgery
RefutedContestedStrong support
consensus score 0.59
Yes for obesity-associated cancers—large cohorts and metas show ~30-40% lower incidence, strongest in women/hormone-related cancers; evidence is observational.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
8 support 1 contradict 2 tested null 4 mixed · 15 sources, 9 independent groups
What the evidence shows
Large cohorts and pooled analyses show roughly 30 to 40 percent lower incidence of obesity-associated cancers after bariatric surgery, strongest in women and for hormone-related cancers, with the Swedish Obese Subjects study following 2,596 women for a median of 24 years. It is observational, and a Nordic cohort of 109,097 operations pointed the other way, so the size is unsettled.
The evidence (24)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Langegård E, Kristensson FM, Andersson-Assarsson JC, Peltonen M, Svensson PA, Jacobson P, Ahlin S, Sjöholm K, Carlsson LMS, Taube M 2026 · Scientific reports | observational | mixed | high | SOS study, 2596 women followed median 23.9y; 135 breast cancer cases (77 control, 58 surgery). Surgery lowered breast cancer incidence in FTO risk-allele carriers (adjusted HR 0.53, 95% CI 0.34-0.83) but not in non-carriers (HR 1.19, 95% CI |
| Ghusn W, El Ghazal N, Klim J, Boutros T, Alomar A, Ghanem O, Laplante S 2026 · Obes Surg | observational | supports | moderate | Propensity-matched multicenter analysis found metabolic/bariatric surgery associated with lower incident malignancy vs dietary counseling. |
| Leijonmarck W, Santoni G, Holmberg D, von Euler-Chelpin M, Ness-Jensen E, Kauppila JH, Lagergren J 2026 · Annals of surgery | observational | contradicts | moderate | Nordic population cohort, 109,097 bariatric surgeries (82,394 gastric bypass) over up to 44 years follow-up; 46 patients developed gastric non-cardia adenocarcinoma. Gastric bypass associated with increased adenocarcinoma risk in the exclud |
| Sjöholm K, Svensson PA, Andersson-Assarsson JC, Jacobson P, Ahlin S, Karlsson C, Carlsson B, Kristensson FM, Karlsson P, Peltonen M, Carlsson LMS, Taube M 2026 · PLoS medicine | observational | mixed | high | SOS post-hoc analysis, 2007 surgery patients vs 2040 controls, median follow-up ~26-27 years. Bariatric surgery lowered overall cancer incidence in women (HRadj 0.78, 95% CI 0.67-0.90) and especially female-specific cancers (HRadj 0.60), bu |
| Ipaye T, Goldney J, Wilkinson TJ, Zaccardi F, Yates T, Davies MJ, Brown K, Papamargaritis D 2025 · Diabetes Obes Metab | observational | supports | moderate | Real-world cohort in type 2 diabetes found weight-loss interventions including bariatric surgery associated with fewer obesity-associated cancers. |
| Abdulmajeed J, Shi Z, Abdel-Rahman ME, Shahid F, Alam MF, Al-Shafai M, Chowdhury MEH, Shaito A, Onitilo AA, Doi SA 2025 · Biomol Biomed | observational | supports | moderate | Target-trial-emulation cohort (124,780 adults) found bariatric surgery associated with roughly halved cancer hazard (HR 0.49). |
| Aminian A, Wilson R, Al-Kurd A, Tu C, Milinovich A, Kroh M, Rosenthal RJ, Brethauer SA, Schauer PR, Kattan MW, Brown JC, Berger NA, Abraham J, Nissen SE 2022 · JAMA | observational | supports | high | SPLENDID matched cohort (30k): surgery cut obesity-associated cancer incidence (HR 0.68) and cancer mortality (HR 0.52). |
| Hu C, Jiang Z, Lu F, Liu X 2026 · Obesity surgery | meta-analysis | supports | moderate | Meta-analysis of 10 cohort studies, 3,929,395 participants. Bariatric surgery associated with significantly lower gallbladder cancer incidence (95% CI 0.35-0.90), with subgroup HRs 0.45-0.6 depending on study size/quality. |
| Rzeska W, Adamiak-Godlewska A 2026 · Biomedicines | observational | supports | moderate | Narrative review on endometrial carcinogenesis stating bariatric surgery 'offers the strongest human evidence' that durable metabolic correction substantially reduces endometrial cancer incidence, in contrast to pharmacologic interventions |
| El Ghazal N, Abedalqader T, Jawhar N, Puvvadi S, Sample JW, Ghanem OM 2026 · Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery | observational | supports | low | Narrative review stating that bariatric-surgery-induced weight loss and hormonal restoration reduces the incidence and mortality of endometrial cancer, among other benefits to women's reproductive health. |
| Jalmood R, Alsafari W, Al-Asiry H, Almutairi M, Alzahrani A, Alahmari S, Alahmadi S, Alalawi G, Almuhaisen M, Albalawi A, Alajlan S, Alsannaa N, Alshehri A 2026 · Obesity surgery | meta-analysis | supports | moderate | Meta-analysis of 8 studies, 793,197 women (140,880 surgery, 652,317 non-surgical). Bariatric surgery associated with lower breast cancer incidence (pooled HR 0.61, 95% CI 0.46-0.80), in both pre- and postmenopausal women. |
| Lim JS, Kim S, Cho IY, Shin DW 2026 · J Obes Metab Syndr | observational | supports | low | Narrative review, not evidence: 'We narratively synthesize recent meta-analyses and selected cohort studies'; 'observational studies and select trials suggest that intentional weight loss' (incl. bariatric surgery) can reduce cancer incidence, 'although estimates are heterogeneous and causal certainty is limited.' Review — zero weight. |
| Shen S, Brown KA, Green AK, Iyengar NM 2026 · JAMA | observational | supports | moderate | Narrative translational review citing observational data: patients losing >10% body weight via bariatric procedures (n=30,318) had modest reductions in obesity-associated cancer incidence (absolute change -0.02% to -0.5%). |
| Liu H, Tian J, Sun X, Li R, Gao W, Zhang D, Dong G 2026 · Obes Surg | observational | mixed | moderate | Review, not evidence: 'This review develops a biologically plausible mechanistic framework for these divergent outcomes.' Cites RYGB CRC risk 'HR 1.55 at 10-14 years' vs no elevation after sleeve from other cohorts. Review — zero weight. |
| Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, Bouchard C, Carlsson B, Karason K, Lönroth H, Näslund I, Sjöström E, Taube M, Wedel H, Svensson PA, Sjöholm K, Carlsson LM 2014 · JAMA | observational | supports | moderate | This report from the Swedish Obese Subjects cohort followed 343 surgery and 260 usual-care patients who had type 2 diabetes at baseline, and measured diabetes remission and vascular complications: remission 72.3% versus 16.4% at 2 years and 30.4% versus 6.5% at 15 years, macrovascular complications 31.7 versus 44.2 per 1000 person-years (hazard ratio 0.68) and microvascular 20.6 versus 41.8 (hazard ratio 0.44). It reports no cancer outcome; the cohort's cancer results appear in a separate publication. |
| Ruffini ML, Fraga BL, Moraes CEAG, Ribeiro DHGF, Sei LJC, Hartmann ML, Matos MR, Lopes RIL, Júnior SC, Toledo SAF, Pessini SA 2025 · Int J Gynaecol Obstet | meta-analysis | supports | moderate | Weight-loss measures (incl. surgery) reduce endometrial cancer risk—hormone-related cancer signal strongest. |
| Stenberg E, Ottosson J, Cao Y, Lagstam I, Näslund E 2025 · Obesity (Silver Spring) | observational | tested-null | moderate | Swedish nationwide matched cohort, 68,424 bariatric surgery patients (2007-2020) vs 640,944 controls 'from the general population' matched on age, sex and area. All-cancer: 'no difference in the risk for new onset of cancer (incidence rate ratio [IRR]: 1.03, 95% CI: 0.99-1.07)'. Lower breast (IRR 0.78, 0.71-0.86) and skin cancer, higher colon, liver, pancreatic, uterine, renal cancers vs the general population. Comparator is not obese non-operated patients, so parity with the general population is neutral to the claim (tested-null), not a test of it. |
| Wilson R, Aminian A 2023 · Surg Obes Relat Dis | observational | supports | moderate | SPLENDID review: substantial sustained weight loss reduces cancer incidence/mortality, consistent with prior cohorts. |
| Clifford JT, Ryan OK, Donnelly M, Davey M, Al-Mukhlifi T, Clerkin ME, Butt WT, O'Shea DF, Boland M, Fearon NM, Heneghan HM 2025 · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | meta-analysis | mixed | moderate | Meta-analysis of 14 studies, 2,288,003 patients. Bariatric surgery reduced overall breast cancer incidence (RR 0.58, 95% CI 0.46-0.72), but subgroup analyses found no statistically significant reduction in premenopausal (RR 0.88) or postmen |
| Reytor-González C, Sarno G, Montalvan M, Verde L, Annunziata G, Barrea L, Muscogiuri G, Simancas-Racines D 2026 · Nutrients | observational | supports | moderate | Narrative review synthesizing epidemiological evidence that bariatric surgery is associated with reduced overall cancer risk and cancer-related mortality for obesity-linked malignancies, while noting the benefit is less consistent for color |
| Wolff Sagy Y, Ramot N, Battat E, Arbel R, Reges O, Dicker D, Lavie G 2025 · EClinicalMedicine | observational | tested-null | moderate | Retrospective cohort found bariatric surgery associated with lower obesity-related cancer incidence than first-generation GLP-1 RAs. |
| Schauer DP 2023 · Surg Obes Relat Dis | observational | mixed | moderate | Review: association robust for obesity-related cancers but confounding and site-specific heterogeneity caution against overgeneralizing. |
| Chen ZW, Jin T, Liang PP, Li ZD, He FJ, Chen ZH, Song XH, Zhu YF, Hu JK, Yang K 2024 · Surg Obes Relat Dis | meta-analysis | supports | high | 33-cohort meta: significantly lower overall and obesity-related cancer incidence after bariatric surgery. |
| Chong KH, Chang YJ, Wang J, Lu KC, Hou TC, Cheng CF, Tsai KW 2026 · Breast (Edinburgh, Scotland) | observational | mixed | moderate | TriNetX cohort, 4,439,072 women with severe obesity. Early sleeve gastrectomy (≤6mo) reduced 5-year breast cancer incidence (RR 0.799) and gynecologic cancer (RR 0.490), but delayed surgery (1-3y) was associated with increased breast cancer |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.